Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...

Among older adults in Spain, hospitalisation rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

Participants were observed for two seasons, from August 31, 2021, to December 18, 2023, to evaluate vaccine efficacy, its safety and the increase in antibody levels against RSV-A and RSV-B variants.

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing ...

GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to protect adults aged 60 years and older against lower ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

A newly released white paper, based on research conducted independently by IQVIA, a global healthcare consultancy, and ...

RSV, a common and contagious virus that affects the lungs and respiratory airways, that can affect people of all ages, from infants to adults. Among adults, it disproportionately affects older adults ...